(CLARIFY) CLoud ARtificial Intelligence For pathologY
Pathology has repeatedly been highlighted as being ripe for innovation in terms of workflow efficiency and more accurate diagnostics. In fact, the estimated market growth for digital pathology systems is huge, with the forecast to reach 143 million dollars by 2019 in the EU and 205 million dollars in the USA. Despite this boost in sales, diagnostic pathology in practice today is still a slow and cumbersome process that relies heavily on the subjective interpretation of a microscopic image by a qualified pathologist. This imposes a limitation, even more substantial in small pathology departments where the pathologists might not be specialized in particular areas.
CLARIFY targets to deliver an innovative, multinational, multi-sectorial, and multidisciplinary research and training programme that link two highly differentiated specialities: engineering and medicine, with a focus on digital pathology.
CLARIFY’s scientific goal is to develop a robust automated digital diagnostic environment based on cutting-edge technologies to enhance knowledge sharing and reach better‐informed decisions.
More detailed information
Role Erasmus MC:
Marie Sklodowska-Curie ITN